This multi-year work culminated almost two years ago now with the complete synthesis of the Mycoplasma genitalium genome 4. At every stage, we've had to develop new methodology and tools.

In this application, ownership is claimed of an organism that contains a reduced version of the genome of Mycoplasma genitalium that is still capable of living freely, growing and replicating.

US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels: Basel Thursday, January 23, 2025, 09:00 Hrs [IST] Roc ...

More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15-49 years old, most of which are asymptomatic.1 FDA CLIA-waived tests broaden access to ...